Showing 2691-2700 of 3315 results for "".
- Shamir Glacier PLUS Metaform on 1.6 and 1.67 Now Availablehttps://modernod.com/news/shamir-glacier-plus-metaform-on-16-and-167-now-available/2481093/Shamir announced the availability of the new Glacier PLUS Metaform lens-coating technology, which uses fewer resources and chemicals in its production than its premium AR coating, making it an eco-friendly option for consumers. According to Shamir, features of the new len
- Johnson & Johnson Vision Launches Acuvue Oasys Max 1-Dayhttps://modernod.com/news/johnson-johnson-vision-launches-acuvue-oasys-max-1-day/2481083/Johnson & Johnson Vision Care announced the launch of its newest innovation, Acuvue Oasys Max 1-Day contact lenses and Acuvue Oasys Max 1-Day Multifocal contact lenses for presbyopia. The lenses are designed with a combination of new technologies to help meet the needs of digit
- Neurolens Raises $67 Million Investment to Develop New Products and Accelerate Adoptionhttps://modernod.com/news/neurolens-raises-67-million-investment-to-develop-new-products-and-accelerate-adoption/2481080/Neurolens announced completion of a $67 million financing to fuel continued product innovation and growth initiatives, further accelerating the adoption of Neurolens. The financing was led by MVM Partners, with additional participation from Falcon Vision/KKR, Marshall Wac
- ESCRS Launches New Awards Program to Foster Digital Transformationhttps://modernod.com/news/escrs-launches-new-awards-program-to-foster-digital-transformation/2481078/The European Society of Cataract & Refractive Surgeons (ESCRS) announced the launch of the 2022 ESCRS Digital Research Awards (DRA), an initiative sponsored by the society to support and encourage innovative research that leads to digital transformation in the fields of cataract, re
- NIH Researchers Develop Gene Therapy for Rare Ciliopathyhttps://modernod.com/news/nih-researchers-develop-gene-therapy-for-rare-ciliopathy/2481074/Researchers from the National Eye Institute (NEI) have developed a gene therapy that rescues cilia defects in retinal cells affected by a type of Leber congenital amaurosis (LCA), a disease that causes blindness in early childhood. Using patient-derived retina organoids (also known as retinas-in-
- American Academy of Ophthalmology Urges CMS to Address Prior Authorization, Other Burdens in Medicare Advantagehttps://modernod.com/news/american-academy-of-ophthalmology-urges-cms-to-address-prior-authorization-other-burdens-in-medicare-advantage/2481072/In a comment letter submitted to the Centers for Medicare and Medicaid Services (CMS), the American Academy of Ophthalmology (AAO), called on CMS to increase oversight and reform prior authorization, step therapy, and medical record requests in Medicare Advantage plans.
- Opus Genetics Hosts Inaugural Patient Advocacy Outreach Webinar on Inherited Retinal Diseaseshttps://modernod.com/news/opus-genetics-hosts-inaugural-patient-advocacy-outreach-webinar-on-inherited-retinal-diseases/2481058/Opus Genetics announced the release of the first patient advocacy outreach webinar featuring presentations by Opus leadership: Ben Yerxa, PhD, and CEO of Opus; Ash Jayagopal, PhD, and chief scientific officer; Joe Schachle, COO; and Jennifer Hunt, chief development officer. The recorded webinar,
- CooperVision MiSight 1 Day Officially Launches in Chinahttps://modernod.com/news/coopervision-misight-1-day-officially-launches-in-china/2481026/CooperVision and EssilorLuxottica have officially launched MiSight 1 day contact lenses in China, marking its availability in the world’s largest country for myopia management. It is the first product of any type that has an indication from the Chinese National Medical Products Adminis
- Staar Surgical Partners with Joe Jonas to Introduce New EVO ICLhttps://modernod.com/news/staar-surgical-partners-with-joe-jonas-to-introduce-new-evo-icl/2481024/Staar Surgical announced its partnership with singer, songwriter, and actor, Joe Jonas, to raise awareness of its EVO Visian Implantable Collamer Lenses (EVO). EVO is an FDA-approved vision correction lens designed for the correction/reduction of myopia and astigmatism. Mr. Jo
- Pixium Vision Announces Regulatory Approval of Remote Rehabilitation System for Patients in Clinical Trialshttps://modernod.com/news/pixium-vision-announces-regulatory-approval-of-remote-rehabilitation-system-for-patients-in-clinical-trials/2481010/Pixium Vision announced the approval of the remote rehabilitation system for patients enrolled in the PRIMAvera pivotal trial and the French Feasibility Study in atrophic dry age-related macular degeneration (AMD). The approval was granted by the Ethics Commitee and the Regulatory Autho